MedTrace Logo

IRIS Registry: Intelligent Research in Sight Registry

NCT02485847 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000000

Last updated 2016-07-12

No results posted yet for this study

Summary

The IRIS™ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.

Conditions

  • Eye Diseases

Interventions

PROCEDURE

Ophthalmology

A registry of ophthalmic ambulatory encounters which captures essential data elements for continuous quality improvement efforts, enhanced patient care outcomes, and pay for performance programs.

Sponsors & Collaborators

  • American Academy of Ophthalmology

    lead OTHER

Principal Investigators

  • Flora Lum, MD · American Academy of Ophthalmology

Eligibility

Min Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2100-01-31
Completion
2100-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02485847 on ClinicalTrials.gov